Rituximab for refractory digital infarcts and ulcers in systemic sclerosis
Journal
Clinical Rheumatology
Journal Volume
33
Journal Issue
7
Pages
1019-1020
Date Issued
2014
Author(s)
Abstract
Systemic sclerosis is an uncommon connective tissue disease characterised by excessive deposition of collagen and vasculopathy which affects the skin and multiple internal organs. It is associated with autoimmunity, inflammation, vasculopathy and fibrosis. Managing Raynaud's phenonemon, digital infarcts and ulcers in systemic sclerosis patients is often a challenge particularly among rheumatologists. We report a case of systemic sclerosis patient with refractory digital infarcts and ulcers responded successfully with rituximab. ? 2014 Clinical Rheumatology.
SDGs
Other Subjects
cyclophosphamide; prostacyclin; rituximab; C reactive protein; monoclonal antibody; rituximab; finger ulcer; gangrene; human; infarction; osteomyelitis; priority journal; quality of life; Raynaud phenomenon; refractory digital infarct; review; scleroderma; sclerosis; systemic sclerosis; vascular disease; adult; autoimmunity; case report; complication; erythrocyte sedimentation rate; finger; inflammation; male; metabolism; pathology; Scleroderma, Systemic; skin; skin ulcer; treatment outcome; Adult; Antibodies, Monoclonal, Murine-Derived; Autoimmunity; Blood Sedimentation; C-Reactive Protein; Fingers; Humans; Inflammation; Male; Scleroderma, Systemic; Skin; Skin Ulcer; Treatment Outcome
Publisher
Springer-Verlag London Ltd
Type
review